He added, "But we didn't know the exact role they play, or how they work to drive lung cancer progression. I think this study ...

The term interstitial lung disease (ILD) refers to a wide variety of conditions in which there is inflammation, scarring or both in the lungs. ILD can be part of a systemic illness or it can only ...

Timing it later in the progression of the disease is not favorable.” “A lot of patients on the wait list are, like Mr.

A tracer known as FAPI performed better than the commonly used 18F-FDG for capturing early signs of pulmonary fibrosis on PET ...

“But we didn’t know the exact role they play, or how they work to drive lung cancer progression. I think this study really ...

In 5-year follow-up data from the phase III CROWN trial of ALK -positive advanced non-small cell lung cancer (NSCLC), ...

For patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), standard use of the more ... compared to ...

Lung cancer is commonly diagnosed as small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC). In America, lung ...

Five years later 60% of patients given lorlatinib were still alive without signs of disease progression, compared to 8% in ...

Practice-changing studies in advanced non-small cell lung cancer presented at ASCO 2024 are reviewed by Dr Ticiana Leal, ...

Our findings show it’s time to routinely adopt IMRT over 3D-CRT for lung cancer, just like we did for prostate ... compared ...

AI’s ability to outperform human lung cancer detection is rapidly evolving, as was highlighted in the clinical science ...